Evidence map›Paper›PMID 40925219›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2025

UGT2B7-mediated drug-drug interaction between cannabinoids and hydromorphone.

Shelby Coates, Keti Bardhi, Mengqi Zhao, Philip Lazarus

Abstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shelby CoatesDepartment of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington.
Keti BardhiDepartment of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington; Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York.
Mengqi ZhaoDivision of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York.
Philip LazarusDepartment of Pharmaceutical Sciences, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, Washington; Division of Molecular Biosciences, Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, New York. Electronic address: plazarus@buffalo.edu.

Funding

Drug-drug interactions between cannabis and hydrocodone.F31DA056197 · NIDA · WASHINGTON STATE UNIVERSITY · PI COATES, SHELBY · 2022 to 2024
$78k
NIDA NIH HHS F31 DA056197
6 · The paper itself

Abstract

Hydromorphone is a highly potent opioid used to treat severe chronic pain. It is metabolized primarily by UDP-glucuronosyltransferase (UGT)2B7 to form the inactive hydromorphone-3-glucuronide. Given that previous studies have shown that the major cannabinoids, Δ

Indexed as

Analgesics, OpioidCannabinoidsGlucuronosyltransferaseHydromorphoneDrug InteractionsGlucuronidesHumansMicrosomes, LiverAnalgesics, OpioidCannabinoidsGlucuronidesGlucuronosyltransferaseHydromorphoneUGT2B7 protein, humanCannabidiolDrug–drug interactionsHydromorphonePhysiologically based pharmacokinetic modelingTetrahydrocannabinolUDP-glucuronosyltransferase

Identifiers

PMID40925219
PMCPMC12597549

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.